Cardiothoracic Department, Policlinico Riuniti Foggia, Foggia, Italy.
Department of Medical and Surgical Sciences, University of Foggia, Italy.
Am J Cardiol. 2024 Nov 1;230:41-46. doi: 10.1016/j.amjcard.2024.08.016. Epub 2024 Aug 24.
Frailty status is linked with a poorer clinical outcome, and patients with frailty are often less revascularized, even with percutaneous coronary intervention (PCI). We therefore sought to assess the impact of frailty on the clinical outcome of older patients with non-ST elevation acute myocardial infarction (NSTEMI) who underwent PCI. We prospectively enrolled 141 consecutive older patients (>75 years) admitted for NSTEMI; 104 patients underwent PCI (35 with frailty, 69 without frailty), and 37 were not revascularized (22 with frailty, 15 without). Patients with frailty were older, less frequently male, more affected by dementia and severe left ventricular dysfunction, and less treated with PCI; patients treated with PCI were younger and less affected by dementia. Thirty-day mortality rates were proportionally higher, from 3% in patients without frailty treated with PCI, to 7% in patients without frailty not treated with PCI, 17% in patients with frailty treated with PCI, and 48% in patients with frailty not treated with PCI (p <0.05). Similarly, 6-month mortality rates were proportionally higher (12%, 29%, 37%, and 71%). At multivariable analysis, frail status was associated to a sixfold increased risk of mortality at 30 days; at 6 months, frail status was associated to a 3.4-fold risk of death (p <0.01), but PCI was also associated to a lower risk of mortality (odds ratio 0.2, p <0.01). In an observational study in older patients with NSTEMI, frail status is associated to a poorer outcome, whereas PCI is associated to a better long-term outcome. A careful selection of patient suitable for revascularization by PCI may be useful in improving outcomes of older patients with frailty with NSTEMI.
虚弱状态与较差的临床结局相关,即使接受经皮冠状动脉介入治疗(PCI),虚弱患者的血运重建也往往较少。因此,我们旨在评估虚弱对接受 PCI 的非 ST 段抬高型急性心肌梗死(NSTEMI)老年患者的临床结局的影响。我们前瞻性纳入了 141 例连续的老年 NSTEMI 患者(>75 岁);104 例患者接受了 PCI(35 例为虚弱,69 例无虚弱),37 例未进行血运重建(22 例为虚弱,15 例无虚弱)。虚弱患者年龄较大,男性较少,痴呆和严重左心室功能障碍的发生率较高,接受 PCI 的治疗率较低;接受 PCI 治疗的患者年龄较小,痴呆的发生率较低。30 天死亡率呈比例升高,无虚弱且接受 PCI 治疗的患者为 3%,无虚弱且未接受 PCI 治疗的患者为 7%,虚弱且接受 PCI 治疗的患者为 17%,虚弱且未接受 PCI 治疗的患者为 48%(p<0.05)。同样,6 个月死亡率呈比例升高(12%、29%、37%和 71%)。多变量分析显示,虚弱状态与 30 天死亡风险增加 6 倍相关;6 个月时,虚弱状态与死亡风险增加 3.4 倍相关(p<0.01),但 PCI 也与较低的死亡率相关(比值比 0.2,p<0.01)。在一项针对 NSTEMI 老年患者的观察性研究中,虚弱状态与较差的结局相关,而 PCI 与较好的长期结局相关。对适合接受 PCI 血运重建的患者进行仔细选择可能有助于改善虚弱 NSTEMI 老年患者的结局。